Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03429101
Title A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.